159 related articles for article (PubMed ID: 14929332)
21. [Chemotherapy of myasthenia].
BAUER H; SCHMID O
Dtsch Z Nervenheilkd; 1953; 169(6):427-37. PubMed ID: 13083321
[No Abstract] [Full Text] [Related]
22. [Case of myasthenia gravis].
KATILA O; KIVALO E
Duodecim; 1955; 71(4):605-10. PubMed ID: 14391241
[No Abstract] [Full Text] [Related]
23. [A case of Erb-Goldflam myasthenia. Trial of a new anti-myasthenic product].
SUTTER ; JORDA ; LEBASCLE
Rev Otoneuroophtalmol; 1953 Apr; 25(3):169-72. PubMed ID: 13075453
[No Abstract] [Full Text] [Related]
24. SOME ASPECTS OF POSITIONING AND STANDARDIZATION IN ENDOCRINOLOGY.
MASON E
Med Biol Illus; 1964 Jan; 14():8-12. PubMed ID: 14116713
[No Abstract] [Full Text] [Related]
25. [Combined prostigmine and acetylcholine in therapy of myasthenia gravis].
ACCORNERO F
Riv Neurol; 1954; 24(2):198-214. PubMed ID: 13195492
[No Abstract] [Full Text] [Related]
26. HYPERTHYROIDISM AND PERIODIC PARALYSIS.
JACKMAN RL; JONES RE
Arch Intern Med; 1964 May; 113():657-64. PubMed ID: 14120588
[No Abstract] [Full Text] [Related]
27. Myasthenia gravis: report of case receiving unusual dosage of neostigmine.
RIDER JA; PICKETT WH; HARRISON AW
Ann Intern Med; 1951 Aug; 35(2):463-8. PubMed ID: 14857617
[No Abstract] [Full Text] [Related]
28. Urecholine in myasthenia gravis.
SCHWARZ H
Can Med Assoc J; 1955 Mar; 72(5):346-51. PubMed ID: 14352096
[No Abstract] [Full Text] [Related]
29. Myasthenia gravis and malignant exophthalmos; report of a case.
ZONDEK H; TICHO A
Lancet; 1951 Dec; 2(6692):1018-20. PubMed ID: 14881540
[No Abstract] [Full Text] [Related]
30. An investigation of the metabolism of neostigmine in patients with myasthenia gravis.
SCOTT CA; NOWELL PT; WILSON A
J Pharm Pharmacol; 1962 Dec; 14(Suppl)():31T-33T. PubMed ID: 13992512
[No Abstract] [Full Text] [Related]
31. [Case of Erb-Goldflam disease (myasthenia)].
BAYULKEM F; UNLUTURK C; OZBEK A; AVCILAR HR
Turk Tip Cemiy Mecm; 1951 Oct; 17(10):542-7. PubMed ID: 14901504
[No Abstract] [Full Text] [Related]
32. MYASTHENIA GRAVIS IN A MUSOGA GIRL. CASE REPORT.
SINGH JS
East Afr Med J; 1964 Nov; 41():535-6. PubMed ID: 14249963
[No Abstract] [Full Text] [Related]
33. Grades of exophthalmos and thyrotropin-binding inhibitory immunoglobulin in patients with myasthenia gravis.
Okada S; Saito E; Ogawa T; Sadamoto K; Kinoshita M
Eur Neurol; 1995; 35(2):99-103. PubMed ID: 7796844
[TBL] [Abstract][Full Text] [Related]
34. [Therapy of pseudoparalytic myasthenia gravis].
Fasshauer K
Dtsch Med Wochenschr; 1975 Oct; 100(44):2283-4. PubMed ID: 1183327
[No Abstract] [Full Text] [Related]
35. Muscle disease of older patients.
Kennedy WR
Geriatrics; 1965 Nov; 20(11):964-8. PubMed ID: 5844443
[No Abstract] [Full Text] [Related]
36. Problems in the diagnosis of myasthenia gravis; a 20-year report of the neostigmine test.
VIETS HR; SCHWAB RS
Trans Am Neurol Assoc; 1955-1956; (80th Meeting):36-41. PubMed ID: 13311994
[No Abstract] [Full Text] [Related]
37. Management of myasthenia gravis.
Lancet; 1982 Jul; 2(8290):135-6. PubMed ID: 6123843
[No Abstract] [Full Text] [Related]
38. [Treatment of myasthenia gravis in children].
Gościńska Z; Kusiak-Dadak M; Miezyński W; Petryk O; Rokosz A
Pediatr Pol; 1972 Apr; 47(4):449-53. PubMed ID: 5022931
[No Abstract] [Full Text] [Related]
39. The intra-arterial injection of neostigmine as a diagnostic test in myasthenia gravis.
HUTCHINSON EC; MATTHEWS WB
J Neurol Neurosurg Psychiatry; 1953 Feb; 16(1):47-8. PubMed ID: 13023440
[No Abstract] [Full Text] [Related]
40. Neostigmine toxicity; report of fatality following diagnostic test for myasthenia gravis.
MERRILL GG
J Am Med Assoc; 1948 May; 137(4):362. PubMed ID: 18858635
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
